Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Louise Vrancken"'
1
Akademický článek
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
Autor: David Kegyes, Catalin Constantinescu, Louise Vrancken, Leo Rasche, Celine Gregoire, Bogdan Tigu, Diana Gulei, Delia Dima, Alina Tanase, Hermann Einsele, Stefan Ciurea, Ciprian Tomuleasa, Jo Caers
Publikováno v: Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-27 (2022)
Abstract Multiple myeloma (MM) is a plasma cell malignancy that affects an increasing number of patients worldwide. Despite all the efforts to understand its pathogenesis and develop new treatment modalities, MM remains an incurable disease. Novel im
Externí odkaz: https://doaj.org/article/a01915a1e84f4fbba4c866ba9a46106f
Zobrazit plný text záznamu
2
Akademický článek
Radiotheranostic Agents in Hematological Malignancies
Autor: Jo Caers, Elodie Duray, Louise Vrancken, Guillaume Marcion, Valentina Bocuzzi, Kim De Veirman, Ahmet Krasniqi, Margaux Lejeune, Nadia Withofs, Nick Devoogdt, Mireille Dumoulin, Amelie Eriksson Karlström, Matthias D’Huyvetter
Publikováno v: Frontiers in Immunology, Vol 13 (2022)
Radioimmunotherapy (RIT) is a cancer treatment that combines radiation therapy with tumor-directed monoclonal antibodies (Abs). Although RIT had been introduced for the treatment of CD20 positive non-Hodgkin lymphoma decades ago, it never found a bro
Externí odkaz: https://doaj.org/article/be1525215bad43ffa1f35ebe39a6b115
Zobrazit plný text záznamu
3
In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease
Autor: Loïc Delens, Yves Beguin, Louise Vrancken, Ludovic Belle, Sophie Servais, Grégory Ehx, Joan Somja, Laurence Seidel, Caroline Ritacco, Gilles Fransolet, Frédéric Baron, Sophie Dubois, Muriel Hannon, Céline Gregoire
Publikováno v: Biology of Blood and Marrow Transplantation. 25:204-215
Acute graft-versus-host disease (aGVHD) is a severe complication of allogeneic hematopoietic stem cell transplantation. The role of Th17 cells in its pathophysiology remains a matter of debate. In this study, we assessed whether enrichment of human p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7812d13093b5c9bafcb8dad30d579cd6
https://doi.org/10.1016/j.bbmt.2018.10.007
Zobrazit plný text záznamu
5
The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene
Autor: Art Branstrom, Kathrin Stangelberger, Jo Caers, Niklas Zojer, Arnold Bolomsky, Elodie Duray, Christina Pfeiffer, Margaux Lejeune, Louise Vrancken, Marla Weetall, Heinz Ludwig, Helene Breid, Joséphine Muller, Wolfgang Hübl, Martin Willheim
Publikováno v: British journal of haematologyReferences. 190(6)
Future progress in the treatment of multiple myeloma (MM) requires both the characterisation of key drivers of the disease and novel, innovative approaches to tackle these vulnerabilities. The present study focussed on the pre-clinical evaluation of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d2cbafc426c0817620d66eca8e0263
https://pubmed.ncbi.nlm.nih.gov/32232850
Zobrazit plný text záznamu
6
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
Autor: Hendrik De Raeve, Sylvia Faict, Jo Caers, Ken Maes, Kim De Veirman, Karin Vanderkerken, Joséphine Muller, Eline Menu, Elke De Bruyne, Rik Schots, Louise Vrancken, Roy Heusschen
Publikováno v: Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 11, Pp 1-12 (2018)
Progression of multiple myeloma (MM) is largely dependent on the bone marrow (BM) microenvironment wherein communication through different factors including extracellular vesicles takes place. This cross-talk not only leads to drug resistance but als
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d4c683b1a872a07030110dd404a203
http://europepmc.org/articles/PMC6224554
Zobrazit plný text záznamu
7
[What is new in the management of multiple myeloma]
Autor: Louise, Vrancken, Joséphine, Muller, Margaux, Lejeune, Céline, Gregoire, Loïc, Delens, Aurélie, Jaspers, Sophie, Servais, Bernard, Prijck, Frédéric, Baron, Jo, Caers, Yves, Beguin
Publikováno v: Revue medicale suisse. 14(615)
Multiple myeloma is the second most frequent hematological malignancy. Unfortunately, it is still incurable. A better understanding of the myeloma pathophysiology favored the development of new therapeutic molecules that improved both survival and qu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b1d2410ea72bb4c5ddff7f06c987cfdd
https://pubmed.ncbi.nlm.nih.gov/30136458
Zobrazit plný text záznamu
8
In Vitro Th17-Polarized Human CD4
Autor: Loïc, Delens, Grégory, Ehx, Joan, Somja, Louise, Vrancken, Ludovic, Belle, Laurence, Seidel, Céline, Grégoire, Gilles, Fransolet, Caroline, Ritacco, Muriel, Hannon, Sophie, Dubois, Yves, Beguin, Frédéric, Baron, Sophie, Servais
Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 25(2)
Acute graft-versus-host disease (aGVHD) is a severe complication of allogeneic hematopoietic stem cell transplantation. The role of Th17 cells in its pathophysiology remains a matter of debate. In this study, we assessed whether enrichment of human p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::73553ba3ea6d68c16963141a9010715d
https://pubmed.ncbi.nlm.nih.gov/30326279
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje